347 related articles for article (PubMed ID: 27308389)
1. The role of splicing factors in deregulation of alternative splicing during oncogenesis and tumor progression.
Shilo A; Siegfried Z; Karni R
Mol Cell Oncol; 2015; 2(1):e970955. PubMed ID: 27308389
[TBL] [Abstract][Full Text] [Related]
2. Alternative splicing and tumor progression.
Ghigna C; Valacca C; Biamonti G
Curr Genomics; 2008 Dec; 9(8):556-70. PubMed ID: 19516963
[TBL] [Abstract][Full Text] [Related]
3. Large-scale analysis of genome and transcriptome alterations in multiple tumors unveils novel cancer-relevant splicing networks.
Sebestyén E; Singh B; Miñana B; Pagès A; Mateo F; Pujana MA; Valcárcel J; Eyras E
Genome Res; 2016 Jun; 26(6):732-44. PubMed ID: 27197215
[TBL] [Abstract][Full Text] [Related]
4. The Cancer Spliceome: Reprograming of Alternative Splicing in Cancer.
El Marabti E; Younis I
Front Mol Biosci; 2018; 5():80. PubMed ID: 30246013
[TBL] [Abstract][Full Text] [Related]
5. Aberrant posttranscriptional processing of hyaluronan synthase 1 in malignant transformation and tumor progression.
Adamia S; Kriangkum J; Belch AR; Pilarski LM
Adv Cancer Res; 2014; 123():67-94. PubMed ID: 25081526
[TBL] [Abstract][Full Text] [Related]
6. Aberrant splicing, hyaluronan synthases and intracellular hyaluronan as drivers of oncogenesis and potential drug targets.
Adamia S; Pilarski PM; Belch AR; Pilarski LM
Curr Cancer Drug Targets; 2013 May; 13(4):347-61. PubMed ID: 23517594
[TBL] [Abstract][Full Text] [Related]
7. Splicing programs and cancer.
Germann S; Gratadou L; Dutertre M; Auboeuf D
J Nucleic Acids; 2012; 2012():269570. PubMed ID: 22132318
[TBL] [Abstract][Full Text] [Related]
8. Splicing-factor alterations in cancers.
Anczuków O; Krainer AR
RNA; 2016 Sep; 22(9):1285-301. PubMed ID: 27530828
[TBL] [Abstract][Full Text] [Related]
9. RNA splicing, cell signaling, and response to therapies.
Abou Faycal C; Gazzeri S; Eymin B
Curr Opin Oncol; 2016 Jan; 28(1):58-64. PubMed ID: 26575690
[TBL] [Abstract][Full Text] [Related]
10. Hallmarks of alternative splicing in cancer.
Oltean S; Bates DO
Oncogene; 2014 Nov; 33(46):5311-8. PubMed ID: 24336324
[TBL] [Abstract][Full Text] [Related]
11. Splicing Factor Mutations in Cancer.
Bejar R
Adv Exp Med Biol; 2016; 907():215-28. PubMed ID: 27256388
[TBL] [Abstract][Full Text] [Related]
12. Cancer-Associated Perturbations in Alternative Pre-messenger RNA Splicing.
Shkreta L; Bell B; Revil T; Venables JP; Prinos P; Elela SA; Chabot B
Cancer Treat Res; 2013; 158():41-94. PubMed ID: 24222354
[TBL] [Abstract][Full Text] [Related]
13. Aberrant Splicing in Cancer: Mediators of Malignant Progression through an Imperfect Splice Program Shift.
Luz FA; Brígido PC; Moraes AS; Silva MJ
Oncology; 2017; 92(1):3-13. PubMed ID: 27794578
[TBL] [Abstract][Full Text] [Related]
14. Splicing factors of SR and hnRNP families as regulators of apoptosis in cancer.
Kędzierska H; Piekiełko-Witkowska A
Cancer Lett; 2017 Jun; 396():53-65. PubMed ID: 28315432
[TBL] [Abstract][Full Text] [Related]
15. Protein kinases that phosphorylate splicing factors: Roles in cancer development, progression and possible therapeutic options.
Czubaty A; Piekiełko-Witkowska A
Int J Biochem Cell Biol; 2017 Oct; 91(Pt B):102-115. PubMed ID: 28552434
[TBL] [Abstract][Full Text] [Related]
16. The role of alternative splicing in cancer.
Singh B; Eyras E
Transcription; 2017 Mar; 8(2):91-98. PubMed ID: 28005460
[TBL] [Abstract][Full Text] [Related]
17. Pre-mRNA splicing in cancer: the relevance in oncogenesis, treatment and drug resistance.
Wojtuszkiewicz A; Assaraf YG; Maas MJ; Kaspers GJ; Jansen G; Cloos J
Expert Opin Drug Metab Toxicol; 2015 May; 11(5):673-89. PubMed ID: 25495223
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic alternative splicing switches: role in cancer progression and prospects for therapy.
Bonomi S; Gallo S; Catillo M; Pignataro D; Biamonti G; Ghigna C
Int J Cell Biol; 2013; 2013():962038. PubMed ID: 24285959
[TBL] [Abstract][Full Text] [Related]
19. Splicing and cancer: Challenges and opportunities.
Coltri PP; Dos Santos MGP; da Silva GHG
Wiley Interdiscip Rev RNA; 2019 May; 10(3):e1527. PubMed ID: 30773852
[TBL] [Abstract][Full Text] [Related]
20. Alternative splicing in cancer: noise, functional, or systematic?
Skotheim RI; Nees M
Int J Biochem Cell Biol; 2007; 39(7-8):1432-49. PubMed ID: 17416541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
